BG set to bid for North Sea's Oranje Nassau-report

LONDON, March 29 (Reuters) - British oil & gas firm BG Group is preparing a bid for up-for-sale North Sea producer Oranje Nassau, a newspaper reported on Sunday.
Source: RSS feed - channel BNewsHealth | 29 Mar 2009 | 1:09 pm

Germany sets limits on Opel aid before Merkel visit

FRANKFURT, March 29 (Reuters) - Germany's economy minister said on Sunday that there were a host of investors interested in troubled carmaker Opel, but warned they could not expect Berlin to assume all...
Source: RSS feed - channel BNewsHealth | 29 Mar 2009 | 12:14 pm

Bangladesh examines Cairn proposal to raise gas price

DHAKA, March 29 (Reuters) - Bangladesh is reviewing a proposal submitted by U.K.-based Cairn Energy Plc , to raise the price of gas sold to state-run oil, gas and mineral corporation Petrobangla, a senior...
Source: RSS feed - channel BNewsHealth | 29 Mar 2009 | 10:44 am

BLS Lymphoedema Awareness Week Launches Dedicated Website, UK

This week the British Lymphology Society launched a dedicated website for its national Lymphoedema Awareness Week. The site, which forms part of the first national campaign to raise awareness of the condition, Lymphoedema, can be found at http://www.blsawarenessweek.co.uk and will carry information for patients as well as healthcare and GP practitioners.
Source: Health News from Medical News Today | 29 Mar 2009 | 9:00 am

Oncoplastic Breast Surgeon, Radiologist, Medical Oncologist, & Pathologist To Lead American Society Of Breast Disease

Society Elects New Officers and 5 Board Members Benjamin O. Anderson, Professor, University of Washington, Seattle, and founder, Breast Health Global Initiative, announced today that nine outstanding leaders in the field of breast cancer were elected to positions on the Society's Board of Directors.
Source: Health News from Medical News Today | 29 Mar 2009 | 9:00 am

Medivir: Epiphany Biosciences Plans On Filing An IND For Valomaciclovir (MIV-606) Targeting MS

Epiphany Biosciences plans on filing an IND at the FDA to study the potential impact of valomaciclovir in patients with multiple sclerosis. Valomaciclovir, (EBP-348, MIV-606) is a compound licensed from Medivir (STO:MVIRB). One of the multiple contributing factors to the disease MS can be Epstein-Barr virus (EBV) and valomaciclovir is active against EBV and other herpes viruses.
Source: Health News from Medical News Today | 29 Mar 2009 | 9:00 am

NHS Delivers Shortest Waits Since Records Began, England

The NHS is celebrating the shortest waits since its records began, Health Secretary Alan Johnson announced today. New data shows that across England the NHS has met its target to treat patients within a maximum of 18 weeks from referral by their GP - an achievement that was unimaginable 12 years ago. The average wait for treatment for admitted patients is now just 8.6 weeks.
Source: Health News from Medical News Today | 29 Mar 2009 | 9:00 am

Vertex Pharmaceuticals Initiates Phase 2 Development For CFTR Corrector VX-809 In Patients With Cystic Fibrosis

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced the initiation of a Phase 2a clinical trial for VX-809, an investigational Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) corrector that targets the defective CFTR protein that causes cystic fibrosis (CF).
Source: Health News from Medical News Today | 29 Mar 2009 | 9:00 am

Cleveland Clinic Recognizes Circulating Tumor Cell Technology As Top Medical Innovation For 2009

Sparton Corporation's (NYSE:SPA) wholly-owned subsidiary, Sparton Medical Systems, Inc., produces the medical equipment that drives the CellSearch® System to measure circulating tumor cells (CTCs).
Source: Health News from Medical News Today | 29 Mar 2009 | 9:00 am

Allos Therapeutics Submits New Drug Application For Pralatrexate For Patients With Relapsed Or Refractory Peripheral T-cell Lymphoma

Allos Therapeutics, Inc. (NASDAQ: ALTH) announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the use of pralatrexate for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
Source: Health News from Medical News Today | 29 Mar 2009 | 9:00 am

Public Back Patient-Held Records Initiative, UK

A scheme to make people responsible for holding and updating their own health records on smartcards has received strong backing in a survey of both patients and healthcare professionals.
Source: Health News from Medical News Today | 29 Mar 2009 | 9:00 am

Automatic Melting Point Detection Simplifies QC Testing

Stuart's new SMP40 automatic melting point apparatus incorporates the latest digital video imaging technology to detect and accurately capture the melting point of up to three samples simultaneously. Walk-away operation speeds high throughput purity testing and the SMP40's USB connectivity facilitates increased traceability of results to meet QC requirements in manufacturing companies.
Source: Health News from Medical News Today | 29 Mar 2009 | 9:00 am

Endocyte Announces Positive Interim Results From Phase II Clinical Trial Of EC145 In Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Endocyte Inc. has announced positive interim results from an ongoing Phase II clinical study of EC145 in patients with advanced non-small cell lung cancer (NSCLC). The single arm Phase II study is designed to evaluate treatment with EC145 in patients with chemotherapy-resistant NSCLC who have failed multiple therapy regimens.
Source: Health News from Medical News Today | 29 Mar 2009 | 9:00 am

Natgas signs found in another Israel drill site

TEL AVIV, March 29 (Reuters) - A U.S.-Israeli exploration group that discovered large amounts of natural gas in Israeli waters earlier this year said on Sunday it found early signs of gas at a new drill...
Source: RSS feed - channel BNewsHealth | 29 Mar 2009 | 7:30 am

India's Sun Pharma gets FDA approval for topiramate

MUMBAI (Reuters) - Indian drug firm Sun Pharmaceutical Industries Ltd said it had received approval from the U.S. Food and Drug Administration to sell topiramate tablets.
Source: RSS feed - channel BNewsHealth | 29 Mar 2009 | 5:48 am

India's Sun Pharma gets FDA approval for topiramate

MUMBAI, March 29 (Reuters) - Indian drug firm Sun Pharmaceutical Industries Ltd said it had received approval from the U.S. Food and Drug Administration to sell topiramate tablets.
Source: RSS feed - channel BNewsHealth | 29 Mar 2009 | 5:44 am

Foreign Ways and War Scars Test Hospital

Hennepin County Medical Center in Minneapolis offers an extraordinary vantage point on the ways immigrants are testing the medical establishment.
Source: NYT > Health | 29 Mar 2009 | 5:19 am

Romania: living at the municipal dump

Face blackened by 35 years spent on a rubbish dump on the outskirts of Cluj, Marin Varga waits for a local recycling company to peruse the few valuable objects he found that morning in the...
Source: RSS feed - channel BNewsHealth | 29 Mar 2009 | 3:58 am

A new personality cult rises in Turkmenistan

Since gaining independence from the Soviet Union in 1991, Turkmenistan, an arid desert nation on the eastern shores of the Caspian Sea, has struggled under a regime known widely for its...
Source: RSS feed - channel BNewsHealth | 29 Mar 2009 | 3:27 am

Sharks pose Sydney food-chain puzzle

Three shark attacks in Sydney in three weeks drove newspapers and talk show hosts into a feeding frenzy and sent a collective shudder through the other species at the top of the food chain...
Source: RSS feed - channel BNewsHealth | 29 Mar 2009 | 3:18 am

Personal Best: It’s Time to Make a Coffee Run

Caffeine is one of the few performance enhancers that are not banned by the World Anti-Doping Agency, and studies have proved that it does work in athletes' favor.
Source: NYT > Health | 29 Mar 2009 | 3:04 am

A Lesson on Health Care From Massachusetts

President Obama aims to lower costs, but Massachusetts focused on expanding access first.
Source: NYT > Health | 29 Mar 2009 | 2:48 am

Out-of-network insurance practices face scrutiny (AP)

In this Jan. 21, 2009 file photo, Senate Commerce, Science, and Transportation Committee Chairman Sen. Jay Rockefeller, D-W.Va., speaks during a hearing on Capitol Hill in Washington.  Rockefeller plans to demand answers Tuesday from the chief executives of UnitedHealthGroup Inc. and its subsidiary Ingenix, a claims database used by insurers nationwide to calculate 'out of network' rates.   (AP Photo/Susan Walsh, File)AP - Ever wonder how that bill was calculated if you had to pay to see a doctor outside your insurance network?



Source: Yahoo! News: Health News | 29 Mar 2009 | 2:01 am

Guidelines Updated for Management of Opportunistic Infections in HIV-Infected Adults and Teens

The Centers for Disease Control, National Institutes of Health, and others have updated guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents.
Medscape Medical News
Source: Medscape Medical News Headlines | 29 Mar 2009 | 12:29 am

Whole-Body CT May Improve Survival for Patients With Polytrauma

A retrospective, multicenter study shows that for patients with polytrauma, integrating whole-body computed tomography into early trauma care significantly increases the probability of survival.
Medscape Medical News
Source: Medscape Medical News Headlines | 29 Mar 2009 | 12:22 am

Proteinuria May Not Help Predict Fetal or Maternal Outcomes in Preeclampsia

A systematic review shows that the estimation of levels of proteinuria in women with preeclampsia is not a clinically useful test to predict fetal or maternal outcomes.
Medscape Medical News
Source: Medscape Medical News Headlines | 29 Mar 2009 | 12:14 am

Dental phobia

How sedation changed trips to the dentist
Source: BBC News | Health | World Edition | 29 Mar 2009 | 12:11 am

Cuba holds first US art exhibit in 50 years

US artists went on show at the 10th Havana Biennial, for the first time since Cuba's 1959 communist revolution, event organizers at the National Art Museum said Saturday. The exhibition,
Source: RSS feed - channel BNewsHealth | 28 Mar 2009 | 11:41 pm

ACC 2009: PROTECT-AF: Device Closure of LAA May Provide Alternative to Warfarin to Prevent Stroke in AF

Results of a randomized open trial showed that in AF patients who were candidates for warfarin therapy, device closure of the LAA using the Watchman device reduced hemorrhagic stroke risk vs warfarin, and all-cause stroke and all-cause mortality outcomes were noninferior to warfarin, although safety events, particularly pericardial effusion, were more common in the device group.
Medscape Medical News
Source: Medscape Medical News Headlines | 28 Mar 2009 | 11:38 pm

ACC 2009: "Healing" Stent Suffers Compared With Bare-Metal Stent in Tiny STEMI Trial

The Genous stent does a cool trick--it's coated with monoclonal antibodies that attract endothelial progenitor cells. But a small study, contrasting a bit with earlier research, fell far short of suggesting that patients receiving the stent for acute MI can stop taking a second antiplatelet agent after 30 days.
Heartwire
Source: Medscape Medical News Headlines | 28 Mar 2009 | 10:49 pm

ACC 2009: Upper-Limb Ischemia During Ambulance Transfer Reduces Myocardial Perfusion Injury in STEMI

Researchers say that occluding the brachial artery during ambulance transfer to induce ischemic conditioning is a simple and safe intervention that has the potential to reduce mortality and morbidity in STEMI patients.
Heartwire
Source: Medscape Medical News Headlines | 28 Mar 2009 | 10:10 pm

ACC 2009: Evidence Growing for Personalized Antiplatelet Therapy

Two more studies have suggested that genotyping and platelet-function tests can identify those patients.
Heartwire
Source: Medscape Medical News Headlines | 28 Mar 2009 | 9:47 pm

ACC 2009: Largest-Ever Real-World Study Lays to Rest Safety Concerns Surrounding DES

Using a unique approach of matching registry figures with Medicare billing data, scientists at Duke University have conducted the largest-ever real-world study to compare long-term outcomes between drug-eluting stents and bare-metal stents. The results should reassure everyone that DES are safe and effective, say the authors.
Heartwire
Source: Medscape Medical News Headlines | 28 Mar 2009 | 9:19 pm

Stroke-blocking device shows promise, doctors say (AP)

AP - A novel device to treat a common heart problem that can lead to stroke showed promise in testing, but not without risk, new research shows.
Source: Yahoo! News: Health News | 28 Mar 2009 | 7:22 pm

Study: Triathlons can pose deadly heart risks (AP)

AP - Warning to weekend warriors: Swim-bike-run triathlons pose at least twice the risk of sudden death as marathons do, the first study of these competitions has found.
Source: Yahoo! News: Health News | 28 Mar 2009 | 5:33 pm

Diet High in Red Meat Tied to Early Age-Related Macular Degeneration

Red meat consumption is positively associated with early age-related macular degeneration (AMD); high intake of chicken, on the other hand, is inversely associated with late AMD, according to findings from a prospective Australian study.
Reuters Health Information
Source: Medscape Medical News Headlines | 28 Mar 2009 | 2:12 pm

ACC 2009: Quality-of-Life and Cost Analyses for SYNTAX Can Help Hone Treatment Decisions Researchers Say

CABG-treated patients have more angina relief at one year, but PCI is the more cost-effective strategy, at least in low- and moderate-risk patients. During the first month, quality-of-life analyses clearly favor PCI, but these differences evaporate over the first year. In high-risk patients, CABG remains the clear winner.
Heartwire
Source: Medscape Medical News Headlines | 28 Mar 2009 | 1:42 pm

Teen Leaders More Likely to Have Kids Later (LiveScience.com)

LiveScience.com - We live in an age of overachieving young people. These kids do great in school, are sports team captains, have lots of friends who follow them around in awe, and get raises at their part-time jobs because they have the skills to get others to work hard too. Some of these kids are overworked and overwhelmed, but others seem to thrive. This sort of busy child will surely get into a good college (unless she burns out before filling out the applications), and those fine-tuned social skills will presumably pay off in terms of getting a decent job and making money. ...
Source: Yahoo! News: Health News | 28 Mar 2009 | 1:32 pm